AARDVARK THERAPEUTICS INC (AARD:NASDAQ)

$1.08 -0.31 (-22.3022%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 56

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed AARDVARK THERAPEUTICS INC (AARD:NASDAQ) News Sources

FDA hold puts Aardvark Prader-Willi drug in limbo

15-05-2026

biopharmadive.com

external link

Several Insiders Invested In Aardvark Therapeutics Flagging Positive News

28-05-2026

yahoo.com

external link

Aardvark Therapeutics Inc (AARD) (Q2 2026) Earnings Call Highlights: Board Re-Elected, Auditor ...

17-08-2026

yahoo.com

external link

Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

02-10-2026

yahoo.com

external link

Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors

08-10-2026

yahoo.com

external link

Prader-Willi Syndrome Market to Expand by 2036 as New Therapeutic Opportunities Address Unmet Clinical Needs | DelveInsight

12-10-2026

yahoo.com

external link

All You Need to Know About Aardvark Therapeutics, Inc. (AARD) Rating Upgrade to Buy

21-10-2026

yahoo.com

external link

Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data

22-10-2026

yahoo.com

external link

Aardvark Therapeutics stock surges as FDA lifts clinical hold

22-10-2026

yahoo.com

external link

Aardvark Therapeutics Reports Exploratory Data from the Terminated HERO and Open-Label Extension Trials

23-10-2026

yahoo.com

external link

AARDVARK THERAPEUTICS INC (AARD:NASDAQ) Sentiment Trend

0 25 50 75 100 7 53 79 87 87 89 20 52 82 3 15-05-2026 28-05-2026 17-08-2026 02-10-2026 08-10-2026 12-10-2026 21-10-2026 22-10-2026 23-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

AARDVARK THERAPEUTICS INC (AARD:NASDAQ) FAQs

toggle

What is the current price of AARDVARK THERAPEUTICS INC (AARD:NASDAQ)?

The current price of AARDVARK THERAPEUTICS INC (AARD:NASDAQ) is $1.08.


toggle

AARDVARK THERAPEUTICS INC (AARD:NASDAQ) absolute price change since previous trading day?

The absolute price change of AARDVARK THERAPEUTICS INC (AARD:NASDAQ) since the previous trading day is $-0.31.


toggle

AARDVARK THERAPEUTICS INC (AARD:NASDAQ) percentage price change since previous trading day?

The percentage price change of AARDVARK THERAPEUTICS INC (AARD:NASDAQ) since the previous trading day is -22.3022%.


toggle

What is the most recent average sentiment score for AARDVARK THERAPEUTICS INC (AARD:NASDAQ)?

The most recent average sentiment score for AARDVARK THERAPEUTICS INC (AARD:NASDAQ) is 56 out of 100.


toggle

What is the most recent average sentiment for AARDVARK THERAPEUTICS INC (AARD:NASDAQ)?

The most recent sentiment for AARDVARK THERAPEUTICS INC (AARD:NASDAQ) is .


SEC-8K** Filing Available For AARDVARK THERAPEUTICS INC (AARD:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

AAON (Aaon Inc)
OKUR (Onkure Therapeutics Inc)
ALKS (Alkermes Plc)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.